China Health Management Corp. is a healthcare and management company focused on the operation and management of hospitals and other facets of the medical industry throughout China. Within three to five years, the company intends to establish a leading position in the high-end medical market in the Yunnan Province and secure a 40% market share of the private medical services industry.
Data shows that the health sensitive, high-consuming population in China is growing by 30% annually with a large market potential. An estimated 2%-5% of consumers in the medical market would opt for high-end medical institutions. The consumers that make up this demographic are white-collar employees or owners of private enterprises who hold a higher educational standing and earn a higher income. With the allocation of medical resources overloading the public hospitals, it makes it difficult to meet the needs of many patients. With these figures, China Health focuses their efforts on the high-end consumers, bringing more personalized medical attention.
President and Director of China Health Management Corp., Dr. Xu Mei, holds a 1984 graduate degree from the China Pharmaceutical University, a B.S. degree in Medicine and Pharmacology, and has more than 20 years of experience in the healthcare field. He founded and was head of the Sinshong Drug Research and Development Center, and served as the head of the department of New Drug Examination at Yunnan Food and Drug Administration. He led the National Laboratory of New Drugs Screening Project, and established the first national class laboratory in China to be approved by the Ministry of Technology.
Let us hear your thoughts below: